TBL-1004HI

N/A

Report date: 2025/01/26 16:34:09
NME

Base Information

Drug NameTBL-1004HI
Drug Alias NameHIV therapy (Transgene Biotek)TBL-1004HI
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTransgene Biotek Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTransgene Biotek Ltd
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A